Ledger.Open graph →
SEC Form D · filed December 22, 2016

Rasna Therapeutics Inc

Offering
$10.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

John P. Brancaccio · New York, NYDirectorKunwar Shailubhai · New York, NYDirectorJane N. Henderson · CHRISTIANSBURG, VADirectorJohn Alex Martin · New York, NYDirectorJames Tripp · New York, NYExec · DirectorJim Mervis · New York, NYDirectorTiziano Lazzaretti · New York, NYExecRiccardo Dalla-Favera · New York, NYDirectorAlessandro Padova · New York, NYDirectorRonald Carner · Brooklyn, NYDirectorRoberta N. Douma · CHRISTIANSBURG, VADirectorJohn Alex Martin · New York, NYDirectorJames Tripp · New York, NYExec · DirectorJim Mervis · New York, NYDirectorTiziano Lazzaretti · New York, NYExecRiccardo Dalla-Favera · New York, NYDirectorAlessandro Padova · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗